Arthritis: all 3,553 studies

Page 10 of 36. Open to participants first (311), then studies with results posted, then the rest; newest registration first within each.

• Milnacipran for Treatment of Pain in Older Adults With Rheumatoid ArthritisCompletedNCT01225991Phase 4Results posted
• Effect of SAR153191 (REGN88) With Methotrexate in Patients With Active Rheumatoid Arthritis Who Failed TNF-α BlockersTerminatedNCT01217814Phase 2Results posted
• Seronegative Oligoarthritis of the Knee Study (SOKS)TerminatedNCT01216631Phase 2Results posted
• An Open Label Study for Participants With Rheumatoid ArthritisTerminatedNCT01215942Phase 3Results posted
• PALACE 3: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic ArthritisCompletedNCT01212770Phase 3Results posted
• PALACE 2: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic ArthritisCompletedNCT01212757Phase 3Results posted
• A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107)CompletedNCT01208181Phase 3Results posted
• Milnacipran in the Treatment of Widespread, Non-Joint Pain in Rheumatoid ArthritisCompletedNCT01207453Phase 4Results posted
• A Study in Participants With Rheumatoid ArthritisTerminatedNCT01202773Phase 3Results posted
• A Rheumatoid Arthritis Study in ParticipantsCompletedNCT01202760Phase 3Results posted
• Role of Oral and Intestinal Microbiota in Rheumatoid Arthritis (RA)CompletedNCT01198509Not applicableResults posted
• A Rheumatoid Arthritis Study in Participants on a Background Treatment of MethotrexateTerminatedNCT01198002Phase 3Results posted
• Evaluation of Effectiveness of Two Dosing Regimens of Fostamatinib Compared to Placebo in Patients With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate and Have Had Inadequate Response to Single TNF-alpha AntagonistCompletedNCT01197755Phase 3Results posted
• Evaluation of Effectiveness of Two Dosing Regimens of Fostamatinib Compared to Placebo in Patients With Rheumatoid Arthritis (RA) Who Are Taking Disease Modifying Anti-rheumatic Drug (DMARD) But Not Responding.CompletedNCT01197534Phase 3Results posted
• Evaluation of Effectiveness of Two Dosing Regimens of Fostamatinib Compared to Placebo in Patients With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Not Responding.CompletedNCT01197521Phase 3Results posted
• A Study of the Effects of RoActemra/Actemra (Tocilizumab) on Neutrophils in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Biologic and/or Non-biologic DMARDs.CompletedNCT01195272Phase 4Results posted
• A Study to Compare Subcutaneous Versus Intravenous Administration of RoActemra/Actemra (Tocilizumab) in Participants With Moderate to Severe Active Rheumatoid ArthritisCompletedNCT01194414Phase 3Results posted
• An Observational Study of the Impact of RoActemra/Actemra on Fatigue in Patients With Rheumatoid Arthritis (PEPS)CompletedNCT01185522Results posted
• A Study in Participants With Rheumatoid Arthritis on Background Methotrexate TherapyCompletedNCT01185353Phase 2Results posted
• Study to Determine the Effects of Different Doses of Methotrexate (MTX) When Taken With Adalimumab in Subjects With Early Rheumatoid Arthritis (RA)CompletedNCT01185301Phase 3Results posted
• A Study to Determine the Effect of Methotrexate (MTX) Dose on Clinical Outcome and Ultrasonographic Signs in Subjects With Moderately to Severely Active Rheumatoid Arthritis (RA) Treated With Adalimumab (MUSICA)CompletedNCT01185288Phase 4Results posted
• Efficacy of NNC0142-0002 in Subjects With Rheumatoid Arthritis (RA)CompletedNCT01181050Phase 2Results posted
• Methotrexate - Inadequate Response Device Sub-StudyCompletedNCT01173120Phase 3Results posted
• Efficacy and Safety Study of Apremilast to Treat Active Psoriatic ArthritisCompletedNCT01172938Phase 3Results posted
• Effectiveness in Daily Practice of Different Treatment Strategies for Early Rheumatoid Arthritis.CompletedNCT01172639Phase 4Results posted
• Safety and Tolerability of AIN457 in Adults (18-65 Years) With Psoriatic ArthritisCompletedNCT01169844Phase 2Results posted
• Jointstrong Intervention for Juvenile ArthritisCompletedNCT01166750Not applicableResults posted
• A Study of the Efficacy and Safety of Adalimumab in Pediatric Subjects With Enthesitis Related ArthritisCompletedNCT01166282Phase 3Results posted
• Effects of Tofacitinib (CP-690,550) on Magnetic Resonance Imaging (MRI)- Assessed Joint Structure In Early Rheumatoid Arthritis (RA)CompletedNCT01164579Phase 2Results posted
• Study to Characterize Demographics, Compliance, Tolerability and Safety in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Prescribed Adalimumab (Humira®) as Part of Routine Clinical CareCompletedNCT01163916Results posted
• A Study of the Effects of RoActemra/Actemra on Vaccination in Patients With Rheumatoid Arthritis on Background Methotrexate (VISARA)CompletedNCT01163747Phase 4Results posted
• The Usability and Injection Time of the Physiolis Syringe and Autoinjector in Rheumatoid Arthritis PatientsCompletedNCT01163617Phase 2Results posted
• Special Investigation of Humira® (Adalimumab) on Long-term Treatment in Patients With Rheumatoid ArthritisCompletedNCT01163318Results posted
• Special Investigation (Follow-up Survey of the Study of Adalimumab (D2E7) for Prevention of Joint Destruction in Patients With Rheumatoid Arthritis in Japan (M06-859 (NCT00870467))CompletedNCT01163292Results posted
• A Canadian Study to Evaluate Early Use of Adalimumab After Methotrexate Failure in Early Rheumatoid ArthritisCompletedNCT01162421Phase 4Results posted
• A Study of RoActemra/Actemra (Tocilizumab) in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Current Non-Biologic and/or Biologic DMARDSCompletedNCT01149057Phase 4Results posted
• Prevalence of Psoriatic Arthritis in Adults With Psoriasis: An Estimate From Dermatology PracticeCompletedNCT01147874Phase 4Results posted
• Can TNF-Alpha Incomplete Secondary Responders Attain a Safe and Efficacious Response Switching to CimziaCompletedNCT01147341Phase 4Results posted
• Long Term Evaluation of Sarilumab in Rheumatoid Arthritis Patients (SARIL-RA-EXTEND)CompletedNCT01146652Phase 3Results posted
• Enbrel-Juvenile Idiopathic Arthritis (JIA) Use Results Survey [All-Case Surveillance]CompletedNCT01145352Results posted
• Time to DMARD (Disease-Modifying Anti-Rheumatic Drug) Treatment and Actual Work Limitation of Patients With Rheumatoid Arthritis in TurkeyCompletedNCT01144598Results posted
• Efficacy and Safety Study of Abatacept Subcutaneous Plus Methotrexate in Inducing Remission in Adults With Very Early Rheumatoid ArthritisCompletedNCT01142726Phase 3Results posted
• Hydroxychloroquine to Improve Insulin Sensitivity in Rheumatoid ArthritisCompletedNCT01132118Phase 3Results posted
• ACP for Local Application in Ankle ArthrodesisTerminatedNCT01131455Not applicableResults posted
• SMART Study: A Study of Re-treatment With MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on Anti-TNF Alfa TherapyCompletedNCT01126541Phase 3Results posted
• Knee Arthroplasty Performed With Conventional and Customized InstrumentationCompletedNCT01124305Phase 4Results posted
• Phase 1 Trial of Type II Collagen (CII) APL A12 in Rheumatoid Arthritis PatientsCompletedNCT01123655Phase 1Results posted
• TL011 in Severe, Active Rheumatoid Arthritis PatientsCompletedNCT01123070Phase 1Results posted
• Exploratory Study of PENNSAID Gel to Treat Symptoms of Knee OsteoarthritisCompletedNCT01119898Phase 2Results posted
• A Study of Tocilizumab (RoActemra/Actemra) Versus Adalimumab in Patients With Rheumatoid ArthritisCompletedNCT01119859Phase 4Results posted
• Real Life Evaluation of Rheumatoid Arthritis in Canadians Taking HUMIRACompletedNCT01117480Results posted
• Efficacy and Safety of Humira® in Patients With Psoriatic Arthritis in Normal Medical PracticeCompletedNCT01111240Results posted
• Iyengar Yoga for Young People With Rheumatoid ArthritisCompletedNCT01096823Not applicableResults posted
• A Study of Tocilizumab as Monotherapy or in Combination With DMARDs in Patients With Moderate to Severe Active Rheumatoid ArthritisCompletedNCT01089023Phase 4Results posted
• Certolizumab Pegol in Subjects With Adult Onset Active and Progressive Psoriatic ArthritisCompletedNCT01087788Phase 3Results posted
• A Study of Laquinimod in Participants With Systemic Lupus Erythematosus (SLE) Active Lupus ArthritisCompletedNCT01085084Phase 2Results posted
• Quality of Life Outcomes of HUMIRA in Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), Ankylosing Spondylitis (AS) After Unsustainable Response to Biologicals and Disease Modifying Antirheumatic DrugsCompletedNCT01083693Results posted
• Clinical Outcomes, Compliance and Effectiveness of Switching From Infliximab or Etanercept to Adalimumab in Patients With Active Rheumatoid Arthritis (RA). A Multicenter Post-Marketing Observational Study in Routine Clinical UseTerminatedNCT01083160Results posted
• Surveillance of Humira Injection in Korean PatientsCompletedNCT01083121Results posted
• Safety and Effectiveness of Adalimumab in Patients Diagnosed With Rheumatoid ArthritisCompletedNCT01078571Results posted
• A Belgian Registry of HUMIRA® (Adalimumab) in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis ( ProAct )CompletedNCT01078558Results posted
• EValuation of HumIRA® in Patients With Active Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis in EASTern European CountriesCompletedNCT01078402Results posted
• Evaluation of the Role of Adalimumab on Extraarticular Manifestation - Bone Metabolism and Bone Mineral Density in Patients With Active Rheumatoid ArthritisCompletedNCT01078155Results posted
• Cost Utility Analyses of Adalimumab Treatment in Patients With Rheumatoid Arthritis (RA)CompletedNCT01078116Results posted
• Effectiveness and Safety of Adalimumab in Rheumatoid Arthritis Patients in Routine Clinical PracticeCompletedNCT01078090Results posted
• A Study of the Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF AgentsCompletedNCT01077362Phase 3Results posted
• Efficacy and Safety of Adalimumab in Patients With Rheumatoid Arthritis in Routine Clinical PracticeCompletedNCT01077258Results posted
• Drug Use Investigation for Humira® - All Patient Investigation for Rheumatoid ArthritisCompletedNCT01076959Results posted
• Safety and Effect on Quality of Life/Work Productivity of Humira in Patients With Rheumatoid ArthritisCompletedNCT01076205Results posted
• An Observational Study on the Safety and Effectiveness of Rituximab in Patients With Severe Active Rheumatoid ArthritisCompletedNCT01071798Results posted
• Observation of Treatment With Certolizumab Pegol in Daily PracticeCompletedNCT01069419Results posted
• A Study With Tocilizumab [RoActemra/Actemra] Monotherapy or in Combination With Methotrexate in Patients With Rheumatoid Arthritis (PICTURE)CompletedNCT01063062Phase 3Results posted
• Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis PatientsCompletedNCT01061736Phase 2/3Results posted
• T Cells and TNF (Tumor Necrosis Factor): The Impact of TNF BlockadeCompletedNCT01060098Results posted
• Study Of The Effects Of Atorvastatin On Cholesterol Levels In Rheumatoid Arthritis Patients Taking CP-690,550CompletedNCT01059864Phase 2Results posted
• Safety and Efficacy of AMG 827 in Subjects With RATerminatedNCT01059448Phase 2Results posted
• A Study to Evaluate the Efficacy and Safety of CAM-3001 (Drug) in Subjects With Rheumatoid ArthritisCompletedNCT01050998Phase 2Results posted
• Botulism Toxin Injection as a Treatment for Arthritis of the Basal Thumb JointTerminatedNCT01045694Phase 4Results posted
• A Study of Tocilizumab in Combination With an Oral Contraceptive in Patients With Rheumatoid ArthritisCompletedNCT01044498Phase 3Results posted
• Comparing The Effectiveness And Safety Of 2 Doses Of An Experimental Drug, CP-690,550, To Methotrexate (MTX) In Patients With Rheumatoid Arthritis Who Have Not Previously Received MTXCompletedNCT01039688Phase 3Results posted
• A Study of Tocilizumab Plus Non-biological DMARD in Patients With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to Non-biological DMARDsCompletedNCT01034397Phase 4Results posted
• Oral CF101 Tablets Treatment in Patients With Rheumatoid ArthritisCompletedNCT01034306Phase 2Results posted
• A Study of Tocilizumab and Methotrexate in Combination or as Monotherapy in Treatment-Naïve Patients With Early Rheumatoid ArthritisCompletedNCT01034137Phase 3Results posted
• Prospective Evaluation of Vitagel for Reduction in Blood Loss and Pain Following Unilateral Total Knee ArthroplastyCompletedNCT01027286Phase 4Results posted
• Evaluation of the Efficacy of the Bipolar Sealer Aquamantys 6.0 in Patients Undergoing Total Hip ArthroplastyCompletedNCT01027195Phase 4Results posted
• Safety and Preliminary Efficacy of MOR103 in Patients With Active Rheumatoid ArthritisCompletedNCT01023256Phase 1/2Results posted
• Internet Self-Management Program With Telephone Support for Adolescents With ArthritisCompletedNCT01011179Not applicableResults posted
• A Study of Tocilizumab With or Without Methotrexate in Patients With Rheumatoid Arthritis.CompletedNCT01010503Phase 4Results posted
• A Study of the Safety and Effectiveness of Ustekinumab in Patients With Psoriatic ArthritisCompletedNCT01009086Phase 3Results posted
• A Study of Tocilizumab as Monotherapy and in Combination With Methotrexate Versus Methotrexate in Patients With Early Moderate to Severe Rheumatoid ArthritisCompletedNCT01007435Phase 3Results posted
• Golimumab in Rheumatoid Arthritis Participants With an Inadequate Response to Etanercept (ENBREL) or Adalimumab (HUMIRA)CompletedNCT01004432Phase 3Results posted
• Efficacy, Pharmacokinetics, Safety, and Immunogenicity Study of Abatacept Administered Subcutaneously to Treat Rheumatoid Arthritis in Japanese PatientsCompletedNCT01001832Phase 2/3Results posted
• A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis and an Inadequate Response to MethotrexateCompletedNCT01000610Phase 4Results posted
• A Study of Tocilizumab in Combination With Disease-Modifying Anti-Rheumatic Drugs (DMARDs) in Participants With Moderate to Severe Active Rheumatoid Arthritis With an Inadequate Response to DMARDsCompletedNCT00996606Phase 3Results posted
• A Study of Tocilizumab Added to DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to DMARDs.CompletedNCT00996203Phase 4Results posted
• Study of KB003 In Biologics-Inadequate Rheumatoid ArthritisTerminatedNCT00995449Phase 2Results posted
• Assessing the Use of Certolizumab Pegol in Adult Subjects With Rheumatoid Arthritis on the Antibody Response When Receiving Influenza Virus and Pneumococcal VaccinesCompletedNCT00993668Phase 4Results posted
• A Study of CDP870 as Add-on Meditation to Methotrexate (MTX) in Patients With Rheumatoid ArthritisCompletedNCT00993317Phase 3Results posted
• Substudy - Low Dose of Abatacept in Subjects With Rheumatoid ArthritisCompletedNCT00989235Phase 3Results posted
• A Study of Tocilizumab in Patients With Active Polyarticular Juvenile Idiopathic ArthritisCompletedNCT00988221Phase 3Results posted

← Arthritis overview